Detection of mutations in hepatitis B virus enhancer 2/core promoter and X protein regions in patients with fatal hepatitis B virus infection

Journal of Medical Virology

Volumn 62, Issue 2, 2000, Pages 167-176

  Honda, Arata ^a   Yokosuka, Osamu ^a,c   Suzuki, Kazuyuki ^b   Saisho, Hiromitsu ^a  

^a CHIBA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

Enhancer 2 core promoter region; Fulminant hepatitis; Hepatitis B virus; Severe exacerbation; X protein region

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DISEASE SEVERITY; ENHANCER REGION; FEMALE; GENE EXPRESSION; GENE MUTATION; GENOME; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PATHOGENESIS; PROMOTER REGION; SCHOOL CHILD; SOLID PHASE EXTRACTION; VIRUS INFECTION;

ADULT; AGED; AMINO ACID SEQUENCE; BASE SEQUENCE; CHILD; ENHANCER ELEMENTS (GENETICS); FEMALE; HEPATITIS B; HEPATITIS B CORE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PROMOTER REGIONS (GENETICS); SEQUENCE ANALYSIS, DNA; TRANS-ACTIVATORS;

DNA VIRUSES; HEPATITIS B VIRUS;

EID: 0033813067     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/1096-9071(200010)62:2<167::AID-JMV7>3.0.CO;2-Z     Document Type: Article

References (50)

1. Complete nucleotide sequences of hepatitis B virus genomes associated with epidemic fulminant hepatitis
2. The hepatitis B virus X-gene product trans-activates both RNA polymerase II and III promoters
3. Identification of three essential regions of hepatitis B virus X protein for trans-activation function
4. Two core promotor mutations identified in a hepatitis B virus strain associated with fulminant hepatitis result in enhanced viral replication
5. Naturally occurring mutations define a novel function of the hepatitis B virus core promoter in core protein expression
6. Subtype ayw variant of hepatitis B virus
7. Mutations preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection
8. Mutations in core nucleotide sequence of hepatitis B virus correlate with fulminant and severe hepatitis
9. Cloning and structural analyses of hepatitis B virus DNAs, subtype adr
10. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli
11. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease
12. Wild-type levels of pregenomic RNA and replication but reduced pre-C RNA and e-antigen synthesis of hepatitis B virus with C(1653) → T, A(1762) → T and G(1764) → A mutations in the core promoter
13. Enhanced replication of a hepatitis B virus mutant associated with an epidemic of fulminant hepatitis
14. Chronic type B hepatitis
15. Detection of mutations in the enhancer 2/core promoter region of hepatitis B virus in patients with chronic hepatitis B virus infection: Comparison with mutations in precore and core regions in relation to clinical status
16. Trans-activation of HLA-DR gene by hepatitis B virus X gene product
17. G to A substitution in the promoter region of the apolipoprotein Al gene is associated with elevated serum apolipoprotein Al and high density lipoprotein choresterol concentrations
18. Complete nucleotide sequence of hepatitis B virus DNA of subtype adr and its conserved gene organization
19. Oncogenic potential of hepatitis B virus
20. Fulminant hepatitis B: Induction by hepatitis virus mutants defective in the precore region and incapable of encoding e antigen
21. Nucleotide sequence analysis of precore region in patients with fulminant hepatitis B in the United States
22. Hepatitis B virus core promoter sequence analysis in fulminant and chronic hepatitis B
23. Mechanism of suppression of hepatitis B virus precore RNA transcription by a frequent double mutation
24. A hepatitis B mutation associated with an epidemic of fulminant hepatitis
25. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis elements
26. Roles of T-cell tolerance in the persistence of hepatitis B virus infection
27. The complete nucleotide sequence of a pre-core mutant of hepatitis B virus implicated in fulminant hepatitis and its biological characterization in chimpanzees
28. Nucleotide sequence of a cloned hepatitis B virus genome, subtype ayr: Comparison with genomes of the other three subtypes
29. Typing hepatitis B virus by homology in nucleotide sequence: Comparison of surface antigen subtypes
30. Mutations in the precore region of hepatitis B virus DNA in patients with fulminant and severe hepatitis
31. The complete nucleotide sequence of the cloned hepatitis B virus DNA: Subtype adr and adw
32. Functional similarities between immunodeficiency virus type 1 and simian virus 40kB proto-enhancers
33. An internal domain of hepatitis B virus X antigen is necessary for transactivating activity
34. The nucleotide sequence and reading frames of a mutant hepatitis B virus adr
35. Two-codon mutations of the HBx define two separate regions necessary for its trans-activation function
36. Hepatitis B virus strains with mutations in the core promoter in patients with fulminant hepatitis
37. Trans-activation of viral enhancers including long terminal repeat of the human immunodeficiency virus by the hepatitis B virus X protein
38. Transactivation of viral enhancers by the hepatitis B virus X protein
39. Mutational analysis of two herpes simplex virus type 1 later promoters
40. Hepatitis B virus genomes of patients with fulminant hepatitis do not share a specific mutation
41. Functional analysis of HBV genomes from patients with fulminant hepatitis
42. Neonatal fulminant hepatitis B: Structural and functional analysis of complete hepatitis B virus genomes from mother and infant
43. Analysis of ras gene mutations in human hepatic malignant tumors by polymerase chain reaction and direct sequencing
44. Identification and cloning of a novel heterogeneous nuclear ribonucleoprotein C-like protein that functions as a transcriptional activator of the hepatitis B virus enhancer II
45. Transcriptional trans-activating function of hepatitis B virus
46. Identification of a region within the HIV LTR is essential for transactivation by HBV gene X
47. Detection and direct sequencing of hepatitis B virus genome by DNA amplification method
48. Transcriptional regulation of precore and pregenomic RNAs of hepatitis B virus
49. The HBV X-ORF encodes a transactivator: A potential factor in viral hepatocarcinogenesis
50. Characterization of functional Sp1 transcription factor binding sites in the hepatitis B virus nucleocapsid promoter